Tuer Patrick William 4

What Happened Patrick William Tuer, Chief Operating Officer of Encompass Health (EHC), was granted a derivative award of 10,502 shares on 2026-03-02 at a reported price of $108.06 per share (value ≈ $1,134,846). Separately, on 2026-02-28, 545 shares were surrendered/withheld to satisfy tax withholding obligations related to vesting, at $107.88 per share (proceeds ≈ $58,795). The 10,502-share item is an award (derivative), not an open-market purchase; the 545-share transaction is a routine tax-withholding disposition.

Key Details

• Dates and amounts:
  • 2026-02-28: 545 shares withheld/surrendered at $107.88 — $58,795 (tax withholding).
  • 2026-03-02: 10,502-share derivative award at $108.06 — $1,134,846 (acquisition).
• Shares owned after transaction: not specified in the provided filing summary.
• Footnotes:
  • F1: The 545 shares were withheld/surrendered to pay the insider's tax withholding on vesting.
  • F2: The derivative award reflects an option that becomes exercisable in equal annual installments over a three‑year period commencing March 2, 2027.
• Filing: Form 4 filed 2026-03-03; no late-filing flag was provided in the summary supplied.

Context

• The 10,502-share entry is a compensation-related derivative award (subject to future exercisability/vesting per F2), not an immediate open-market buy. Such awards are common for executives and reflect compensation rather than direct market sentiment.
• The 545-share disposition was a cashless/tax-withholding event — routine and generally not interpreted as an active sell decision by the executive.
• For investors: derivative grants can be meaningful for alignment with shareholders but differ from purchases, which usually carry clearer positive signals about an insider's view of the stock.